Impaired ketogenesis ties metabolism to T cell dysfunction in COVID-19.
3-Hydroxybutyric Acid
/ biosynthesis
Amino Acids
/ biosynthesis
Animals
COVID-19
/ complications
Diet, Ketogenic
Energy Metabolism
Esters
/ metabolism
Glutathione
/ biosynthesis
Glycolysis
Interferon-gamma
/ biosynthesis
Ketone Bodies
/ metabolism
Ketones
/ metabolism
Mice
Orthomyxoviridae
/ pathogenicity
Oxidation-Reduction
Oxidative Phosphorylation
Respiratory Distress Syndrome
/ complications
SARS-CoV-2
/ pathogenicity
T-Lymphocytes
/ immunology
Journal
Nature
ISSN: 1476-4687
Titre abrégé: Nature
Pays: England
ID NLM: 0410462
Informations de publication
Date de publication:
09 2022
09 2022
Historique:
received:
28
07
2021
accepted:
20
07
2022
pubmed:
29
7
2022
medline:
24
9
2022
entrez:
28
7
2022
Statut:
ppublish
Résumé
Anorexia and fasting are host adaptations to acute infection, and induce a metabolic switch towards ketogenesis and the production of ketone bodies, including β-hydroxybutyrate (BHB)
Identifiants
pubmed: 35901960
doi: 10.1038/s41586-022-05128-8
pii: 10.1038/s41586-022-05128-8
pmc: PMC9428867
doi:
Substances chimiques
Amino Acids
0
Esters
0
Ketone Bodies
0
Ketones
0
Interferon-gamma
82115-62-6
Glutathione
GAN16C9B8O
3-Hydroxybutyric Acid
TZP1275679
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
801-807Investigateurs
Zeinab Abdullah
(Z)
Eicke Latz
(E)
Susanne Schmidt
(S)
Gunther Hartmann
(G)
Hendrik Streeck
(H)
Beate M Kümmerer
(BM)
Commentaires et corrections
Type : CommentIn
Informations de copyright
© 2022. The Author(s), under exclusive licence to Springer Nature Limited.
Références
Troha, K. & Ayres, J. S. Metabolic adaptations to infections at the organismal level. Trends Immunol. 41, 113–125 (2020).
pubmed: 31959515
pmcid: 7409656
doi: 10.1016/j.it.2019.12.001
Wilhelm, C., Surendar, J. & Karagiannis, F. Enemy or ally? Fasting as an essential regulator of immune responses. Trends Immunol. 42, 389–400 (2021).
pubmed: 33865714
doi: 10.1016/j.it.2021.03.007
Rao, S. et al. Pathogen-mediated inhibition of anorexia promotes host survival and transmission. Cell 168, 503–516 (2017).
pubmed: 28129542
pmcid: 5324724
doi: 10.1016/j.cell.2017.01.006
Puchalska, P. & Crawford, P. A. Multi-dimensional roles of ketone bodies in fuel metabolism, signaling, and therapeutics. Cell Metab. 25, 262–284 (2017).
pubmed: 28178565
pmcid: 5313038
doi: 10.1016/j.cmet.2016.12.022
Wang, A. et al. Opposing effects of fasting metabolism on tissue tolerance in bacterial and viral inflammation. Cell 166, 1512–1525 (2016).
pubmed: 27610573
pmcid: 5555589
doi: 10.1016/j.cell.2016.07.026
Medzhitov, R., Schneider, D. S. & Soares, M. P. Disease tolerance as a defense strategy. Science 335, 936–941 (2012).
pubmed: 22363001
pmcid: 3564547
doi: 10.1126/science.1214935
Ayres, J. S. Immunometabolism of infections. Nat. Rev. Immunol. 20, 79–80 (2020).
pubmed: 31892735
doi: 10.1038/s41577-019-0266-9
Guan, W. J. et al. Clinical characteristics of coronavirus disease 2019 in China. N. Engl. J. Med. 382, 1708–1720 (2020).
pubmed: 32109013
doi: 10.1056/NEJMoa2002032
Zhu, N. et al. A novel coronavirus from patients with pneumonia in China, 2019. N. Engl. J. Med. 382, 727–733 (2020).
pubmed: 31978945
pmcid: 7092803
doi: 10.1056/NEJMoa2001017
Fan, E. et al. COVID-19-associated acute respiratory distress syndrome: is a different approach to management warranted? Lancet Respir. Med. 8, 816–821 (2020).
pubmed: 32645311
pmcid: 7338016
doi: 10.1016/S2213-2600(20)30304-0
Zheng, H. Y. et al. Elevated exhaustion levels and reduced functional diversity of T cells in peripheral blood may predict severe progression in COVID-19 patients. Cell. Mol. Immunol. 17, 541–543 (2020).
pubmed: 32203186
pmcid: 7091621
doi: 10.1038/s41423-020-0401-3
Steinert, E. M., Vasan, K. & Chandel, N. S. Mitochondrial metabolism regulation of T cell-mediated immunity. Annu. Rev. Immunol. 39, 395–416 (2021).
pubmed: 33902315
doi: 10.1146/annurev-immunol-101819-082015
Stefan, N., Birkenfeld, A. L. & Schulze, M. B. Global pandemics interconnected—obesity, impaired metabolic health and COVID-19. Nat. Rev. Endocrinol. 17, 135–149 (2021).
pubmed: 33479538
doi: 10.1038/s41574-020-00462-1
Zhu, L. et al. Association of blood glucose control and outcomes in patients with COVID-19 and pre-existing type 2 diabetes. Cell Metab. 31, 1068–1077 e1063 (2020).
pubmed: 32369736
pmcid: 7252168
doi: 10.1016/j.cmet.2020.04.021
Del Valle, D. M. et al. An inflammatory cytokine signature predicts COVID-19 severity and survival. Nat. Med. 26, 1636–1643 (2020).
pubmed: 32839624
pmcid: 7869028
doi: 10.1038/s41591-020-1051-9
Merad, M. & Martin, J. C. Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages. Nat. Rev. Immunol. 20, 355–362 (2020).
pubmed: 32376901
pmcid: 7201395
doi: 10.1038/s41577-020-0331-4
Huang, C. et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395, 497–506 (2020).
pubmed: 31986264
pmcid: 7159299
doi: 10.1016/S0140-6736(20)30183-5
Kox, M., Waalders, N. J. B., Kooistra, E. J., Gerretsen, J. & Pickkers, P. Cytokine levels in critically ill patients with COVID-19 and other conditions. J. Am. Med. Assoc. 324, 1565–1567 (2020).
doi: 10.1001/jama.2020.17052
Sinha, P., Matthay, M. A. & Calfee, C. S. Is a "cytokine storm" relevant to COVID-19? JAMA Intern. Med. 180, 1152–1154 (2020).
pubmed: 32602883
doi: 10.1001/jamainternmed.2020.3313
Wendisch, D. et al. SARS-CoV-2 infection triggers profibrotic macrophage responses and lung fibrosis. Cell 184, 6243–6261 (2021).
pubmed: 34914922
pmcid: 8626230
doi: 10.1016/j.cell.2021.11.033
Chen, Z. & John Wherry, E. T cell responses in patients with COVID-19. Nat. Rev. Immunol. 20, 529–536 (2020).
pubmed: 32728222
pmcid: 7389156
doi: 10.1038/s41577-020-0402-6
Grifoni, A. et al. Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals. Cell 181, 1489–1501 (2020).
pubmed: 32473127
pmcid: 7237901
doi: 10.1016/j.cell.2020.05.015
Rydyznski Moderbacher, C. et al. Antigen-specific adaptive immunity to SARS-CoV-2 in acute COVID-19 and associations with age and disease severity. Cell 183, 996–1012 (2020).
pubmed: 33010815
pmcid: 7494270
doi: 10.1016/j.cell.2020.09.038
Sekine, T. et al. Robust T Cell immunity in convalescent individuals with asymptomatic or mild COVID-19. Cell 183, 158–168 (2020).
pubmed: 32979941
pmcid: 7427556
doi: 10.1016/j.cell.2020.08.017
Braun, J. et al. SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19. Nature 587, 270–274 (2020).
pubmed: 32726801
doi: 10.1038/s41586-020-2598-9
Tan, A. T. et al. Early induction of functional SARS-CoV-2-specific T cells associates with rapid viral clearance and mild disease in COVID-19 patients. Cell Rep. 34, 108728 (2021).
pubmed: 33516277
pmcid: 7826084
doi: 10.1016/j.celrep.2021.108728
Zhao, J. et al. Airway memory CD4
pubmed: 27287409
pmcid: 4917442
doi: 10.1016/j.immuni.2016.05.006
Goldberg, E. L. et al. Ketogenic diet activates protective γδ T cell responses against influenza virus infection. Sci. Immunol. 4, eaav2026 (2019).
pubmed: 31732517
pmcid: 7189564
doi: 10.1126/sciimmunol.aav2026
Ryu, S. et al. Ketogenic diet restrains aging-induced exacerbation of coronavirus infection in mice. eLife 10, e66522 (2021).
pubmed: 34151773
pmcid: 8245129
doi: 10.7554/eLife.66522
Zhang, H. et al. Ketogenesis-generated β-hydroxybutyrate is an epigenetic regulator of CD8
pubmed: 31871320
doi: 10.1038/s41556-019-0440-0
Hirschberger, S. et al. Very-low-carbohydrate diet enhances human T-cell immunity through immunometabolic reprogramming. EMBO Mol. Med. 13, e14323 (2021).
pubmed: 34151532
pmcid: 8350890
doi: 10.15252/emmm.202114323
Arguello, R. J. et al. SCENITH: a flow cytometry-based method to functionally profile energy metabolism with single-cell resolution. Cell Metab. 32, 1063–1075 (2020).
pubmed: 33264598
pmcid: 8407169
doi: 10.1016/j.cmet.2020.11.007
Desdin-Mico, G. et al. T cells with dysfunctional mitochondria induce multimorbidity and premature senescence. Science 368, 1371–1376 (2020).
pubmed: 32439659
doi: 10.1126/science.aax0860
Keating, S. E. et al. Metabolic reprogramming supports IFN-γ production by CD56
pubmed: 26873994
doi: 10.4049/jimmunol.1501783
Franchina, D. G., Dostert, C. & Brenner, D. Reactive oxygen species: involvement in T cell signaling and metabolism. Trends Immunol. 39, 489–502 (2018).
pubmed: 29452982
doi: 10.1016/j.it.2018.01.005
Su, Y. et al. Multi-omics resolves a sharp disease-state shift between mild and moderate COVID-19. Cell 183, 1479–1495 (2020).
pubmed: 33171100
pmcid: 7598382
doi: 10.1016/j.cell.2020.10.037
Thomas, T. et al. COVID-19 infection alters kynurenine and fatty acid metabolism, correlating with IL-6 levels and renal status. JCI Insight 5, e140327 (2020).
pmcid: 7453907
doi: 10.1172/jci.insight.140327
Ma, E. H. et al. Serine is an essential metabolite for effector T cell expansion. Cell Metab. 25, 482 (2017).
pubmed: 28178570
doi: 10.1016/j.cmet.2017.01.014
Thompson, E. A. et al. Metabolic programs define dysfunctional immune responses in severe COVID-19 patients. Cell Rep. 34, 108863 (2021).
pubmed: 33691089
pmcid: 7908880
doi: 10.1016/j.celrep.2021.108863
Siska, P. J. et al. Metabolic imbalance of T cells in COVID-19 is hallmarked by basigin and mitigated by dexamethasone. J. Clin. Invest. 131, e148225 (2021).
pubmed: 34779418
pmcid: 8592546
doi: 10.1172/JCI148225
Pearce, E. L., Poffenberger, M. C., Chang, C. H. & Jones, R. G. Fueling immunity: insights into metabolism and lymphocyte function. Science 342, 1242454 (2013).
pubmed: 24115444
pmcid: 4486656
doi: 10.1126/science.1242454
Lutas, A. & Yellen, G. The ketogenic diet: metabolic influences on brain excitability and epilepsy. Trends Neurosci. 36, 32–40 (2013).
pubmed: 23228828
doi: 10.1016/j.tins.2012.11.005
Kennedy, A. R. et al. A high-fat, ketogenic diet induces a unique metabolic state in mice. Am. J. Physiol. Endocrinol. Metab. 292, E1724–E1739 (2007).
pubmed: 17299079
doi: 10.1152/ajpendo.00717.2006
Cox, P. J. et al. Nutritional ketosis alters fuel preference and thereby endurance performance in athletes. Cell Metab. 24, 256–268 (2016).
pubmed: 27475046
doi: 10.1016/j.cmet.2016.07.010
Winkler, E. S. et al. SARS-CoV-2 infection of human ACE2-transgenic mice causes severe lung inflammation and impaired function. Nat. Immunol. 21, 1327–1335 (2020).
pubmed: 32839612
pmcid: 7578095
doi: 10.1038/s41590-020-0778-2
Osuchowski, M. F. et al. The COVID-19 puzzle: deciphering pathophysiology and phenotypes of a new disease entity. Lancet Respir. Med. 9, 622–642 (2021).
pubmed: 33965003
pmcid: 8102044
doi: 10.1016/S2213-2600(21)00218-6
Hu, Z. J. et al. Lower circulating interferon-gamma is a risk factor for lung fibrosis in COVID-19 patients. Front. Immunol. 11, 585647 (2020).
pubmed: 33133104
pmcid: 7550399
doi: 10.3389/fimmu.2020.585647
Faulk, D. M. et al. ECM hydrogel coating mitigates the chronic inflammatory response to polypropylene mesh. Biomaterials 35, 8585–8595 (2014).
pubmed: 25043571
pmcid: 5942585
doi: 10.1016/j.biomaterials.2014.06.057
Whittaker, P., Kloner, R. A., Boughner, D. R. & Pickering, J. G. Quantitative assessment of myocardial collagen with picrosirius red staining and circularly polarized light. Basic Res. Cardiol. 89, 397–410 (1994).
pubmed: 7535519
doi: 10.1007/BF00788278
Nguyen, D. M. et al. An automated algorithm to quantify collagen distribution in aortic wall. J. Histochem. Cytochem. 67, 267–274 (2019).
pubmed: 30452870
doi: 10.1369/0022155418814231
Matute-Bello, G. et al. An official American Thoracic Society workshop report: features and measurements of experimental acute lung injury in animals. Am. J. Respir. Cell Mol. Biol. 44, 725–738 (2011).
pubmed: 21531958
pmcid: 7328339
doi: 10.1165/rcmb.2009-0210ST
Peukert, K. et al. Inhibition of caspase-1 with tetracycline ameliorates acute lung injury. Am. J. Respir. Crit. Care Med. 204, 53–63 (2021).
pubmed: 33760701
pmcid: 8437127
doi: 10.1164/rccm.202005-1916OC
Sapcariu, S. C. et al. Simultaneous extraction of proteins and metabolites from cells in culture. MethodsX 1, 74–80 (2014).
pubmed: 26150938
pmcid: 4472845
doi: 10.1016/j.mex.2014.07.002